OncoSil Medical Ltd (OSL)
CXA CXA Primary Summary
OncoSil Medical Ltd (OSL) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has OncoSil Medical Ltd ever had a stock split?
OncoSil Medical Ltd Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Nigel Lange CEO | CXA Exchange | - ISIN |
| Australia Country | - Employees | - Last Dividend | 3 Jun 2025 Last Split | - IPO Date |
Overview
OncoSil Medical Limited is a pioneer in the medical device industry, specializing in the innovation and commercialization of localized radiation therapy solutions. Founded in 2005 and based in Macquarie Park, Australia, the company has made significant strides in addressing some of the most challenging cancers, including pancreatic and distal cholangiocarcinoma, on a global scale. Through dedicated research and development, OncoSil Medical is striving to transform cancer treatment by offering targeted therapies that promise to improve the quality of life for patients worldwide.
Products and Services
-
OncoSil™
A groundbreaking brachytherapy device, OncoSil is at the forefront of OncoSil Medical's product line. It is specifically designed for the treatment of patients with locally advanced pancreatic cancer. This innovative device works by delivering targeted radiation therapy directly into the cancerous tissue, minimizing exposure to surrounding healthy tissues. OncoSil is indicated for use in combination with gemcitabine-based chemotherapy, offering a new hope for patients battling this aggressive form of cancer. The product encapsulates OncoSil Medical's commitment to advancing cancer treatment technologies and improving patient outcomes.
